泰康医疗健康股票发起C(015140)利润分配表
| |
2025-12-31 |
2025-06-30 |
2024-12-31 |
2024-06-30 |
| 收入 |
-28,267,494.12 |
-21,902,347.73 |
-19,559,690.54 |
-60,768,989.16 |
| 利息合计 |
270,061.84 |
197,407.66 |
732,077.83 |
450,660.29 |
| 其中:存款利息收入 |
144,357.81 |
103,471.29 |
447,332.31 |
246,391.94 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
125,704.03 |
93,936.37 |
284,745.52 |
204,268.35 |
| 投资收益合计 |
-24,944,040.77 |
-27,923,149.60 |
-31,270,847.17 |
-22,099,385.80 |
| 其中:股票投资收益 |
-28,224,688.29 |
-31,045,230.51 |
-38,159,917.36 |
-27,711,140.91 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
-6,829.05 |
-8,927.61 |
84,441.19 |
68,946.93 |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
3,287,476.57 |
3,131,008.52 |
6,804,629.00 |
5,542,808.18 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
-3,937,884.39 |
5,604,549.05 |
10,667,129.38 |
-39,171,189.53 |
| 其他收入 |
344,369.20 |
218,845.16 |
311,949.42 |
50,925.88 |
| 费用 |
3,964,782.51 |
2,806,940.96 |
6,404,382.54 |
3,311,265.15 |
| 管理人报酬 |
2,873,826.55 |
2,040,103.51 |
4,842,787.62 |
2,539,148.26 |
| 基金托管费 |
359,228.38 |
255,012.94 |
605,348.47 |
317,393.59 |
| 销售服务费 |
579,478.66 |
433,926.92 |
800,543.37 |
373,718.55 |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
1,492.16 |
1,492.16 |
3,719.98 |
- |
| 其中:卖出回购金融资产支出 |
1,492.16 |
1,492.16 |
3,719.98 |
- |
| 其他费用 |
150,755.09 |
76,405.43 |
151,982.86 |
81,004.58 |
| 利润总额 |
-32,232,276.63 |
-24,709,288.69 |
-25,964,073.08 |
-64,080,254.31 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年